skip to content
Media
Careers
About Roche
About Roche
Strategy
Our partnerships
Social impact
The Blue Tree Program
About LEAP
History
Solutions
Solutions
Focus areas
Stories
worldwide
About Roche
explore
Strategy
Our partnerships
Social impact
The Blue Tree Program
About LEAP
History
Solutions
explore
Focus areas
Stories
Media
Careers
Media
Media Releases
2023
2022
2020
2019
2018
2017
2016
Roche unveils its first ever Customer Experience Center in Chennai
24.08.2023
Roche inaugurated a state-of-the-art Offshore Development Center (ODC)
07.07.2023
Medical experts view the SEC recommendation for Tecentriq for metastatic urothelial cancer as a promising development for cancer patients in the country.
12.09.2022
Key statement on the emergency use authorisation and supply of the investigational antibody cocktail casirivimab and imdevimab in India.
08.08.2022
Roche's statement on Tocilizumab (Actemra) supplies
08.08.2022
Statement on Ronapreve™
15.06.2022
US-FDA Approved Foundation Medicine's foundationone®Liquid cdx, a Pan-Tumor Liquid Biopsy Genomic Test for Late Stage Cancer Patients now Available in India
18.11.2020
Roche Pharma India expands partnership with Cipla to further improve access to key oncology medicines
18.06.2020
Roche Pharma India partners with Entero Healthcare Solutions to improv
18.06.2020
V. Simpson Emmanuel appointed as General Manager, Roche Products (India) Pvt. Ltd.
05.05.2020
Roche’s Atezolizumab receives DCGI approval for treatment of metastatic triple-negative breast cancer in India
08.04.2020
Roche’s Atezolizumab receives DCGI approval for treatment of extensive-stage small cell lung cancer in India
21.11.2019
Roche Pharma India partners with Cipla to create greater access to key medicines
02.27.2018
Company Statement: Delhi High Court Interim Order on Trastuzumab
03.03.2017
Approval of biosimilars must be subject to rigorous clinical and regulatory standards.
25.04.2016
Downloads
2024
2023
2022
2021
2019
Roche Launches Ocrevus® (Ocrelizumab) -a Breakthrough Blockbuster Therapy, Redefining Multiple Sclerosis (MS) Treatment in India
19.03.2024
PDF
Roche launches Vabysmo® (faricimab), the first and only bispecific monoclonal antibody for the eye, to treat two leading causes of vision loss
19.03.2024
PDF
Roche unveils its first ever Customer Experience Center in Chennai
24.08.2023
PDF
Roche and ZS partner to set up dedicated center in Chennai
07.07.2023
PDF
Roche Pharma India Launches Patient Support App To Help Patients Seamlessly Navigate Their Care Journey
29.11.2022
PDF
Roche expands its Global Analytics and Technology Center of Excellence
18.10.2022
PDF
Roche's Evrysdi (Risdiplam) - the first and only oral treatment for adults and children two months or older suffering from Spinal Muscular Atrophy (SMA) now available in India
29.07.2021
PDF
Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India
24.05.2021
PDF
Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19
05.05.2021
PDF
Company statement on Tocilizumab (Brand: Actemra) supplies
28.04.2021
PDF
Roche launches new therapy Emicizumab for people with Hemophilia A on World Hemophilia Day
17.04.2019
PDF
Roche and St. Jude India ChildCare Centre come together with Dr. B Barooah Cancer Institute to offer holistic cancer care to underprivileged children
10.02.2019
PDF